Cargando…
Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far
The 2019 novel coronavirus disease (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to global public health. Although primarily, the infection causes lung injury, liver enzyme abnormalities have also been reported to occur during the...
Autores principales: | Anirvan, Prajna, Bharali, Pankaj, Gogoi, Mrinal, Thuluvath, Paul J, Singh, Shivaram P, Satapathy, Sanjaya K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772728/ https://www.ncbi.nlm.nih.gov/pubmed/33442447 http://dx.doi.org/10.4254/wjh.v12.i12.1182 |
Ejemplares similares
-
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021) -
What we know so far
Publicado: (2021) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021) -
Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022)